137 related articles for article (PubMed ID: 4397820)
1. The serum concentration of bactericidal antibiotics (rifampicin, cephaloridine) in relation to the low resistance period in experimental infections. Immunological investigations in experimental chemotherapy. V.
Sackmann W
Chemotherapy; 1971; 16(3):203-10. PubMed ID: 4397820
[No Abstract] [Full Text] [Related]
2. The role of the low resistance period in determining the effective dosage of chlortetracycline in mice. Immunological investigations in experimental chemotherapy. IV.
Sackmann W
Chemotherapy; 1971; 16(3):196-202. PubMed ID: 4397819
[No Abstract] [Full Text] [Related]
3. Immunological investigations in experimental chemotherapy. 3. The initial period of low resistance in bacterial infections of mice in relation to bacteriostatic chemotherapy.
Sackmann W
Chemotherapia (Basel); 1968; 13(5):276-88. PubMed ID: 4889161
[No Abstract] [Full Text] [Related]
4. [Dosage and method of action of bactericidal drugs in relation to the "low resistance period" in animal experiment].
Sackmann W
Pathol Microbiol (Basel); 1970; 36(5):284. PubMed ID: 4935368
[No Abstract] [Full Text] [Related]
5. Immunological investigations in experimental chemotherapy. II. Resistance to re-infection, its specificity and dependence upon the inoculum.
Sackmann W
Chemotherapy; 1966; 11(2):95-103. PubMed ID: 4380958
[No Abstract] [Full Text] [Related]
6. Immunological investigations in experimental chemotherapy. I. The susceptibility of mice to homologous re-infection following antibacterial treatment.
Sackmann W
Chemotherapy; 1966; 11(2):86-94. PubMed ID: 4380957
[No Abstract] [Full Text] [Related]
7. [Antibacterial effect of rifampicin and its chemotherapeutic properties in experiments on animals].
Shorin VA; Shapovalova SP; Malkova IV
Antibiotiki; 1974 Dec; 19(12):1084-8. PubMed ID: 4155605
[No Abstract] [Full Text] [Related]
8. [Immunological studies of experimental chemotherapy. IV. The significance of resistance to infection for the dosage of chlortetracycline in the mouse].
Sackmann W
Pathol Microbiol (Basel); 1969; 34(3):155-7. PubMed ID: 4392347
[No Abstract] [Full Text] [Related]
9. Clinical evaluation of cephaloridine.
Steigbigel NH; Kislak JW; Tilles JG; Finland M
Arch Intern Med; 1968 Jan; 121(1):24-38. PubMed ID: 5635071
[No Abstract] [Full Text] [Related]
10. [The antibacterial and chemotherapeutic activity of the Soviet produced antibiotic rifamitsina SV].
Shorin VA; Shapovalova SP
Antibiotiki; 1974 Jan; 19(1):3-6. PubMed ID: 4156904
[No Abstract] [Full Text] [Related]
11. Rifampicin: a new rifamycin. I. Bacteriological studies.
Arioli V; Pallanza R; Furesz S; Carniti G
Arzneimittelforschung; 1967 May; 17(5):523-9. PubMed ID: 4385644
[No Abstract] [Full Text] [Related]
12. [Production of a new antibiotic, chalcidin, from Micromonospora chalcea culture].
Gauze GF; Brazhnikova MG; Shorin VA; Maksimova TS; Ol'khovatova OL; Kudinova MK; Vishniakova IA; Pevzner NS; Shapovalova SP
Antibiotiki; 1970 Jun; 15(6):483-6. PubMed ID: 4394064
[No Abstract] [Full Text] [Related]
13. [Microbiological evaluation of a new synthetic cephalosporin, cephapirin (author's transl)].
Nakazawa S; Otsuki M; Kida K; Sakamichi T; Tanaka S
Jpn J Antibiot; 1974 Apr; 27(2):164-73. PubMed ID: 4152697
[No Abstract] [Full Text] [Related]
14. [Fundamental studies on synthetic cephalosporin antibiotics. 2. Therapeutic effects of oral administration on experimental infections in mice and their distribution in the body].
Nakazawa S; Tsuji A; Watanaba Y; Tsujimoto S
J Antibiot B; 1967 Aug; 20(4):254-8. PubMed ID: 4866093
[No Abstract] [Full Text] [Related]
15. [Bacteriological and pharmacological properties of new cephalosperine antibiotics. II. Cephaloridine].
Naumann P
Arzneimittelforschung; 1967 Apr; 17(4):469-81. PubMed ID: 4386771
[No Abstract] [Full Text] [Related]
16. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
17. Letter: New antibacterial agent via photofluorination of a bacterial cell wall constituent.
Kollonitsch J; Barash L; Kahan FM; Kropp H
Nature; 1973 Jun; 243(5406):346-7. PubMed ID: 4147634
[No Abstract] [Full Text] [Related]
18. An evaluation of sulfasymazine in infections in mice.
Redin GS; McCoy ME
Chemotherapy; 1966; 11(6):309-14. PubMed ID: 5338947
[No Abstract] [Full Text] [Related]
19. Cephaloridine: clinical and laboratory studies in children.
Azimi PH; Cramblett HG
J Pediatr; 1968 Aug; 73(2):255-61. PubMed ID: 4875772
[No Abstract] [Full Text] [Related]
20. [Bacteriological studies on cefatrizine (S-640 P) (author's transl)].
Matsuzaki M; Tado N; Hirata Y; Kato M; Nakumura K
Jpn J Antibiot; 1976 Jan; 29(1):61-8. PubMed ID: 4635
[No Abstract] [Full Text] [Related]
[Next] [New Search]
